Epigenetic factors and cardiac development

Cardiovascular Research

Volumn 91, Issue 2, 2011, Pages 203-211

  Van Weerd, Jan Hendrick ^a,b   Koshiba Takeuchi, Kazuko ^a   Kwon, Chulan ^c   Takeuchi, Jun K ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Baf60c; Cardiac cell fate; Cardiac reprogramming; Cardiac transcription factors; Chromatin remodelling factors; Epigenetics

Indexed keywords

CAUSE OF DEATH; CONGENITAL HEART MALFORMATION; EPIGENETICS; GENETIC TRANSCRIPTION; HEART DEVELOPMENT; HUMAN; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART DEFECTS, CONGENITAL; HUMANS; MORPHOGENESIS; MUSCLE DEVELOPMENT; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 79959953828     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr138     Document Type: Review

References (107)

1. Abu-Issa R, Kirby ML. Heart field: from mesoderm to heart tube. Annu Rev Cell Dev Biol 2007;23:45-68.
2. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835.
3. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell 2006; 127:1101-1104. (Pubitemid 44894531)
4. Moorman AFM, Webb S, Brown NA, Lamers W, Anderson RH. Development of the heart: (1) formation of the cardiac chambers and arterial trunks. Heart 2003;89: 806-814. (Pubitemid 36760653)
5. Christoffels VM, Habets PE, Franco D, Campione M, de Jong F, Lamers WH et al. Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol 2000;223:266-278. (Pubitemid 30485592)
6. Moorman AFM, Christoffels VM. Cardiac chamber formation: development, genes, and evolution. Physiol Rev 2003;83:1223-1267. (Pubitemid 37222272)
7. Black BL. Transcriptional pathways in second heart field development. Semin Cell Dev Biol 2007;18:67-76. (Pubitemid 46343797)
8. Mima T, Ueno H, Fischman DA, Williams LT, Mikawa T. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci USA 1995;92:467-471.
9. Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf1-expressing cells in pharyngeal mesoderm. Dev Cell 2001;1:435-440. (Pubitemid 33586092)
10. Mjaatvedt CH, Nakaoka T, Moreno-Rodriguez R, Norris RA, Kern MJ, Eisenberg CA et al. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol 2001;238:97-109. (Pubitemid 32939289)
11. Waldo KL, Kumiski DH, Wallis KT, Stadt HA, Hutson MR, Platt DH et al. Conotrun-cal myocardium arises from a secondary heart field. Development 2001;128: 3179-3188. (Pubitemid 32825761)
12. Yuasa S, Itabashi Y, Koshimizu U, Tanaka T, Sugimura K, Kinoshita M et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 2005;23:607-611. (Pubitemid 41724900)
13. Klaus A, Saga Y, Taketo MM, Tzahor E, Birchmeier W. Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis. Proc Natl Acad Sci USA 2007;20: 18531-18536. (Pubitemid 350210731)
14. Alsan BH, Schultheiss TM. Regulation of avian cardiogenesis by Fgf8 signaling. Development 2002;129:1935-1943. (Pubitemid 34874208)
15. Lough J, Barron M, Brogley M, Sugi Y, Bolender DL, Zhu X. Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev Biol 1996;178:198-202. (Pubitemid 26297253)
16. Monzen K, Shiojima I, Hiroi Y, Kudoh S, Oka T, Takimoto E et al. Bone morphogen-etic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol Cell Biol 1999;19:7096-7105. (Pubitemid 29441891)
17. Van Wijk B, Moorman AF, van den Hoff MJ. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 2007;74:244-255. (Pubitemid 46517505)
18. Cohen ED, Wang Z, Lepore JJ, Lu MM, Taketo MM, Epstein DJ et al. Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest 2007;117:1794-1804. (Pubitemid 47036313)
19. Kwon C, Arnold J, Hsiao E, Taketo MM, Conklin BR, Srivastava D. Canonical Wnt signaling is a positive regulator in mammalian cardiogenesis. Proc Natl Acad Sci USA 2007;104:10894-10899. (Pubitemid 47175197)
20. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006;127:1151-1165. (Pubitemid 44895618)
21. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006;127:1137-1150. (Pubitemid 44914005)
22. Bruneau BG. The developmental genetics of congenital heart disease. Nature 2008; 451:943-948. (Pubitemid 351301750)
23. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-1900. (Pubitemid 34628268)
24. Hoffman JI. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 1995;16:155-165.
25. Felsenfeld G, Groudine M. Controlling the double helix. Nature 2003;421:448-453. (Pubitemid 36157954)
26. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004;116:259-272. (Pubitemid 38167316)
27. Woodcock CL, Dimitrov S. Higher-order structure of chromatin and chromosomes. Curr Opin Genet Dev 2001;11:130-135. (Pubitemid 32209195)
28. Kornberg RD. Chromatin structure: a repeating unit of histones and DNA. Science 1974;184:868-871.
29. Luo RX, Dean DC. Chromatin remodeling and transcriptional regulation. J Natl Cancer Inst 1999;91:1288-1294. (Pubitemid 29387570)
30. Delgado-Olguin P, Takeuchi JK, Bruneau BG. Chromatin modification and remodeling in heart development. ScientificWorldJournal 2006;6:1851-1861.
31. Ho L, Crabtree GR. Chromatin remodelling during development. Nature 2010;463: 474-484.
32. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009;12:32-42.
33. Wu JI, Lessard J, Crabtree GR. Understanding the words of chromatin regulation. Cell 2009;136:200-206.
34. Lin W, Dent SY. Functions of histone-modifying enzymes in development. Curr Opin Genet Dev 2006;16:137-142. (Pubitemid 43376059)
35. Varga-Weisz P. ATP-dependent chromatin remodeling factors: nucleosome shufflers with many missions. Oncogene 2001;20:3076-3085. (Pubitemid 32553562)
36. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002;108:475-487. (Pubitemid 34260873)
37. Vignali M, Hassan AH, Neely KE, Workman JL. ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 2000;20:1899-1910. (Pubitemid 30123807)
38. De La Serna IL, Ohkawa Y, Imbalzano AN. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 2006;7: 461-473. (Pubitemid 43780489)
39. Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005;15:163-176. (Pubitemid 40416728)
40. Bhaumik SR, Smith E, Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 2007;14:1008-1016. (Pubitemid 350060343)
41. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 2006;75:243-269. (Pubitemid 44118033)
42. Verdone L, Caserta M, Di Mauro E. Role of histone acetylation in the control of gene expression. Biochem Cell Biol 2005;85:344-353. (Pubitemid 41297202)
43. Lee DY, Teyssier C, Strahl BD, Stallcup MR. Role of protein methylation in regulation of transcription. Endocr Rev 2005;26:147-170.
44. Gutierrez RM, Hnilica LS. Tissue specificity of histone phosphorylation. Science 1967; 157:1324-1325.
45. Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 2003;100:13225-13230. (Pubitemid 37444723)
46. Dhananjayan SC, Ismail A, Nawaz Z. Ubiquitin and control of transcription. Essays Biochem 2005;41:69-80. (Pubitemid 41500971)
47. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epige-nomics. Nature Rev Genet 2008;9:465-476. (Pubitemid 351693975)
48. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321: 209-213. (Pubitemid 16016411)
49. Bruneau BG. Chromatin remodeling in heart development. Curr Opin Genet Dev 2010;20:505-511.
50. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 1996;10:2117-2130. (Pubitemid 26303868)
51. Kadam S, Emerson BM. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 2003;11:377-389. (Pubitemid 36293832)
52. Takeuchi JK, Lou X, Alexander JM, Sugizaki H, Delgado-Olguin P, Holloway AK et al. Chromatin remodelling complex dosage modulates transcription factor function in heart development. Nat Commun 2011;2:187.
53. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010;466:62-67.
54. Côté J, Quinn J, Workman JL, Peterson CL. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 1994;265:53-60. (Pubitemid 24253171)
55. Takeuchi JK, Bruneau BG. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009;459:708-712.
56. Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004;432:107-112. (Pubitemid 39490836)
57. Takeuchi JK, Lickert H, Bisgrove BW, Sun X, Yamamoto M, Chawengsaksophak K et al. Baf60c is a nuclear Notch signaling component required for the establishment of left-right asymmetry. Proc Natl Acad Sci USA 2007;104:846-851. (Pubitemid 46154699)
58. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001;106:709-721. (Pubitemid 32900662)
59. Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, Davidson L et al. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 2006;297:566-586. (Pubitemid 44354936)
60. Wang Z, Zhai W, Richardson JA, Olson EN, Meneses JJ, Firpo MT et al. Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes Dev 2004;15:3106-3116. (Pubitemid 39658178)
61. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994;8:1007-1018.
62. Kim JK, Huh SO, Choi H, Lee KS, Shin D, Lee C et al. Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol 2001;21:7787-7795. (Pubitemid 32988787)
63. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 2000;1:500-506.
64. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998;95:279-289. (Pubitemid 28473788)
65. Xue Y, Wong J, Moreno GT, Young MK, Côté J, Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998;2:851-861. (Pubitemid 128378992)
66. Kaji K, Caballero IM, MacLeod R, Nichols J, Wilson VA, Hendrich B. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat Cell Biol 2006;8:285-292. (Pubitemid 43336071)
67. Kaji K, Nichols J, Hendrich B. Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development 2007;134: 1123-1132. (Pubitemid 46630080)
68. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ et al. A histone H3 lysine 36 trimethyltransferase links Nkx-5 to Wolf-Hirschhorn syndrome. Nature 2009;460:287-292.
69. Lu J, Jeong HW, Kong N, Yang Y, Carroll J, Luo HR et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PloS One 2009;4:e5577.
70. Koshiba-Takeuchi K, Takeuchi JK, Arruda EP, Kathiriya IS, Mo R, Hui CC et al. Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart. Nat Genet 2006;38:175-183. (Pubitemid 43177230)
71. Bergemann AD, Cole F, Hirschhorn K. The etiology of Wolf-Hirschhorn syndrome. Trends Genet 2005;21:188-195. (Pubitemid 40269858)
72. Gottlieb PD, Pierce SA, Sims RJ, Yamagishi H, Weihe EK, Harriss JV et al. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 2002;31:25-32.
73. Leinhart K, Brown M. SET/MYND lysine methyltransferase regulate gene transcription and protein activity. Genes 2011;2:210-218.
74. Tan X, Rotllant J, Li H, De Deyne P, Du SJ. SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos. Proc Natl Acad Sci USA 2006;103:2713-2718.
75. Monzen K, Ito Y, Naito AT, Kasai H, Hiroi Y, Hayashi D et al. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat Cell Biol 2008;10:567-574. (Pubitemid 351627376)
76. Reiter JF, Alexander J, Rodaway A, Yelon D, Patient R, Holder N et al. Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev 1999;13:2983-2995.
77. Latinkić BV, Kotecha S, Mohun TJ. Induction of cardiomyocytes by GATA4 in Xenopus ectodermal explants. Development 2003;130:3865-3876. (Pubitemid 37039090)
78. Lickert H, Kutsch S, Kanzler B, Tamai Y, Taketo MM, Kemler R. Formation of multiple hearts in mice following deletion of b-catenin in the embryonic endoderm. Dev Cell 2002;3:171-181.
79. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol 2003;258:1-19. (Pubitemid 36637027)
80. Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R et al. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep 2002;3:69-75. (Pubitemid 34144818)
81. Small EM, Warkman AS, Wang DZ, Sutherland LB, Olson EN, Krieg PA. Myocardin is sufficient and necessary for cardiac gene expression in Xenopus. Development 2005;132:987-997. (Pubitemid 40484933)
82. Stennard FA, Harvey RP. T-box transcription factors and their roles in regulatory hierarchies in the developing heart. Development 2005;132:4897-4910. (Pubitemid 41764003)
83. Hoogaars WM, Barnett P, Moorman AF, Christoffels VM. T-box factors determine cardiac design. Cell Mol Life Sci 2007;64:646-660.
84. Takeuchi JK, Ohgi M, Koshiba-Takeuchi K, Shiratori H, Sakaki I, Ogura K et al. Tbx5 specifies the left/right ventricles and ventricular septum position during cardiogen-esis. Development 2003;130:5953-5964. (Pubitemid 38008799)
85. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 1997;15:21-29. (Pubitemid 27014945)
86. Mori AD, Bruneau BG. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 2004;19:211-215. (Pubitemid 38657439)
87. Koshiba-Takeuchi K, Mori AD, Kaynak BL, Cebra-Thomas J, Sukonnik T, Georges RO et al. Reptilian heart development and the molecular basis of cardiac chamber evolution. Nature 2009;461:95-98.
88. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
89. Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988;242:405-411.
90. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 2003;100:7129-7134. (Pubitemid 36706404)
91. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-386.
92. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128:707-719. (Pubitemid 46273570)
93. Basson M. Singling out heart cells. Nat Med 2007;13:33. (Pubitemid 46067382)
94. Kawai T, Takahashi T, Esaki M, Ushikoshi H, Nagano S, Fujiwara H et al. Efficient car-diomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J 2004;68:691-702. (Pubitemid 38906628)
95. Gonzales C, Pedrazzini T. Progenitor cell therapy for heart disease. Exp Cell Res 2009;315:3077-3085.
96. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, Bernshausen A et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J 2010;24:700-711.
97. Nussbaum J, Minami E, Laflamme MA, Virag JAI, Ware CB, Masino A et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007;21:1345-1357. (Pubitemid 46684837)
98. Kami D, Shiojima I, Makino H, Matsumoto K, Takahashi Y, Ishii R et al. Gremlin enhances the determined path to cardiomyogenesis. PloS One 2008;3:2407.
99. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Guanju Ji et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997;29:1525-1539. (Pubitemid 27270224)
100. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garćia-Verdugo JM, Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neu-rogenesis. Neuron 2000;28:713-726. (Pubitemid 32038066)
101. Lim JY, Kim WH, Kim J, Park SI. Involvement of TGF-b1 signaling in cardiomyocyte differentiation from P19CL6 cells. Mol Cells 2007;24:431-436.
102. Kattman SJ, Huber TL, Keller GM. Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006;11:723-732. (Pubitemid 44644969)
103. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells of the heart. Dev Cell 2003;5:877-889. (Pubitemid 37527688)
104. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell- derived population. Nature 2008;453:524-528. (Pubitemid 351733312)
105. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 2010;120:1125-1139.
106. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S et al. Nonge-netic method for purifying stem cell-derived cardiomyocytes. Nat Methods 2010;7: 61-66.
107. Kwon C, Qian L, Cheng P, Nigam V, Arnold J, Srivastava D. A Regulatory pathway involving Notch/b-Catenin/Isl1 determines cardiac progenitor cell fate. Nat Cell Biol 2009;11:951-957.